Venous thromboembolism (VTE) is a major cause of maternal morbidity during pregnancy
and the postpartum period. However, because there is a lack of adequate study data …

Background Venous thromboembolism (VTE) in pregnancy is an important cause of
maternal morbidity and mortality. Low-molecular-weight heparin (LMWH) is the cornerstone …

Pregnancy‐related venous thromboembolism (VTE) remains one of the leading causes of
maternal mortality and morbidity in the developed world. There is a lack of high‐level data …

Background: During pregnancy, women might weigh the benefits of treatment against
potential risks to the unborn child. However, non-adherence to necessary treatment can …

Introduction Trust in healthcare and medication, defined as feelings of reassurance and
confidence in the healthcare system or medication, may be a key prerequisite before …

The prevention and treatment of venous thromboembolism (VTE) poses distinct gender‐
specific challenges. Women of childbearing age are at an increased risk of VTE secondary …

Background—The optimal dosing strategy of low-molecular-weight heparins for the
treatment of antenatal venous thromboembolism is not known. The physiological changes …

Cerebrovascular accident, or stroke, is the fourth leading cause of death for all women and
the eighth leading cause of pregnancy‐associated death. The physiologic changes of …

Clinical studies are needed to clarify the use of direct oral anticoagulants (DOACs) in
breastfeeding women. To support emerging clinical studies on investigating DOAC's transfer …

Background. Telemedicine technology is widely used especially after the COVID‐19
pandemic. It can be used to give medical advice as well as follow up with the patients at …